作者: Antje Kullowatz , Frank Kanniess , Bernhard Dahme , Helgo Magnussen , Thomas Ritz
DOI: 10.1016/J.RMED.2006.06.002
关键词: Public health 、 Hospital Anxiety and Depression Scale 、 Anxiety disorder 、 Quality of life (healthcare) 、 Psychiatry 、 Health care 、 Anxiety 、 Psychopathology 、 Medicine 、 Depression (differential diagnoses)
摘要: Summary Introduction Demographic factors, symptom severity, and psychopathology, in particular anxiety depression, are known to influence health care use quality of life asthma. Because depression typically correlated, we sought explore whether specifically is associated with utilization when effects controlled for. Method In a cross-sectional questionnaire study, 88 asthma patients (46 women; age range 27–70 years) reported on symptoms treatment their disease, as well (Hospital Anxiety Depression Scale, HADS), general (Short Form 12 Health Survey Questionnaire, SF-12) asthmatic-specific (Living Asthma, LAQ). Results While no considerable associations between were found, the higher scores hospital visits days corticosteroid intake significant. Furthermore, variance all subscales questionnaires was explained by even controlling for anxiety. For these comparable, except physical well-being. Conclusion an important issue asthma, it substantially related corticosteroids, marginally hospitalization. Routine screening should be considered primary care.